Britannia Life Sciences Statistics

Total Valuation

CSE:BLAB has a market cap or net worth of CAD 14.60 million. The enterprise value is 16.18 million.

Market Cap	14.60M
Enterprise Value	16.18M

Important Dates

The last earnings date was Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

CSE:BLAB has 162.25 million shares outstanding. The number of shares has decreased by -0.03% in one year.

Current Share Class	162.25M
Shares Outstanding	162.25M
Shares Change (YoY)	-0.03%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	36.78%
Owned by Institutions (%)	n/a
Float	102.58M

Valuation Ratios

The trailing PE ratio is 1.78.

PE Ratio	1.78
Forward PE	n/a
PS Ratio	56.04
PB Ratio	2.89
P/TBV Ratio	2.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	1.97
EV / Sales	62.10
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.00, with a Debt / Equity ratio of 0.48.

Current Ratio	1.00
Quick Ratio	0.38
Debt / Equity	0.48
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-27.52

Financial Efficiency

Return on equity (ROE) is -58.92% and return on invested capital (ROIC) is -16.18%.

Return on Equity (ROE)	-58.92%
Return on Assets (ROA)	-10.34%
Return on Invested Capital (ROIC)	-16.18%
Return on Capital Employed (ROCE)	-37.52%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +80.00% in the last 52 weeks. The beta is -0.11, so CSE:BLAB's price volatility has been lower than the market average.

Beta (5Y)	-0.11
52-Week Price Change	+80.00%
50-Day Moving Average	0.09
200-Day Moving Average	0.07
Relative Strength Index (RSI)	47.12
Average Volume (20 Days)	77,331

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CSE:BLAB had revenue of CAD 260,580 and earned 8.22 million in profits. Earnings per share was 0.05.

Revenue	260,580
Gross Profit	-160,952
Operating Income	-2.74M
Pretax Income	-3.32M
Net Income	8.22M
EBITDA	-2.63M
EBIT	-2.74M
Earnings Per Share (EPS)	0.05

Full Income Statement

Balance Sheet

The company has 861,631 in cash and 2.44 million in debt, giving a net cash position of -1.58 million or -0.01 per share.

Cash & Cash Equivalents	861,631
Total Debt	2.44M
Net Cash	-1.58M
Net Cash Per Share	-0.01
Equity (Book Value)	5.05M
Book Value Per Share	0.03
Working Capital	12,369

Full Balance Sheet

Cash Flow

Operating Cash Flow	-4.40M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is -61.77%, with operating and profit margins of -1,050.23% and 3,155.76%.

Gross Margin	-61.77%
Operating Margin	-1,050.23%
Pretax Margin	-1,273.99%
Profit Margin	3,155.76%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CSE:BLAB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.03%
Shareholder Yield	0.03%
Earnings Yield	56.31%
FCF Yield	n/a

Stock Splits

The last stock split was on November 18, 2021. It was a reverse split with a ratio of 0.1.

Last Split Date	Nov 18, 2021
Split Type	Reverse
Split Ratio	0.1

Scores

CSE:BLAB has an Altman Z-Score of -1.55 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.55
Piotroski F-Score	3